DSS vs JAZZ · rev $19.1M vs P/E 1988, rev $4.07B
DSS Inc (DSS) versus Jazz Pharmaceuticals PLC (JAZZ) — a side-by-side from cached financials, not a winner call.
DSS Inc (DSS) is a packaging & containers company listed on US.
Jazz Pharmaceuticals PLC (JAZZ) is a biotechnology company listed on US.
Latest reported DSS revenue for 2024-12-31 was $19.1M. Net income was -$53.7M. Revenue was down 26.4% from 2023-12-31 to 2024-12-31. DSS currently screens at market cap $8.3M.
Latest reported JAZZ revenue for 2024-12-31 was $4.07B. Net income was $560.1M. Revenue was up 6.1% from 2023-12-31 to 2024-12-31. JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1.
DSS currently screens at market cap $8.3M. JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1.
Not investment advice. Open the DSS and JAZZ stock pages for the full models.
Not investment advice.